Cargando…
Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test
Colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths in the United States. Screening has been shown to be effective in reducing colorectal cancer incidence and mortality. Colonoscopy, sigmoidoscopy, and fecal occult blood tests are all recommended s...
Autores principales: | Ned, Renée M., Melillo, Stephanie, Marrone, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050633/ https://www.ncbi.nlm.nih.gov/pubmed/21487548 http://dx.doi.org/10.1371/currents.RRN1220 |
Ejemplares similares
-
Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability: Application: Pharmacogenomics
por: Ned, Renée M.
Publicado: (2010) -
Genetic Testing for Lynch Syndrome in Individuals Newly Diagnosed with Colorectal Cancer to Reduce Morbidity and Mortality from Colorectal Cancer in Their Relatives
por: Coates, Ralph, et al.
Publicado: (2011) -
Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011) -
Comprehensive Carrier Screening and Molecular Diagnostic Testing for Recessive Childhood Diseases
por: Kingsmore, Stephen
Publicado: (2012) -
BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer
por: Lea, Andrew, et al.
Publicado: (2010)